R

Read Gene SA
WSE:RDG

Watchlist Manager
Read Gene SA
WSE:RDG
Watchlist
Price: 4.96 PLN -0.8% Market Closed
Market Cap: 58.5m PLN
Have any thoughts about
Read Gene SA?
Write Note

Read Gene SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Read Gene SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
R
Read Gene SA
WSE:RDG
Revenue
zł11.6m
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
41%
M
Mabion SA
WSE:MAB
Revenue
zł110.8m
CAGR 3-Years
312%
CAGR 5-Years
N/A
CAGR 10-Years
72%
G
Genomed SA
WSE:GEN
Revenue
zł22.5m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Revenue
zł177.6m
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
U
Urteste SA
WSE:URT
Revenue
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Revenue
zł57.4m
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
6%
No Stocks Found

Read Gene SA
Glance View

Market Cap
58.5m PLN
Industry
Biotechnology

Read-Gene SA engages in the medical research and testing. The company is headquartered in Szczecin, Woj. Zachodniopomorskie. The company went IPO on 2009-02-12. The company is focused on technologies which aim is to detect, prevent and treat malignant tumors. The firm specializes in three fields: chemoprevention, clinical trials and genetic testing. The company offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The firm operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.

RDG Intrinsic Value
2.52 PLN
Overvaluation 49%
Intrinsic Value
Price
R

See Also

What is Read Gene SA's Revenue?
Revenue
11.6m PLN

Based on the financial report for Jun 30, 2024, Read Gene SA's Revenue amounts to 11.6m PLN.

What is Read Gene SA's Revenue growth rate?
Revenue CAGR 10Y
41%

Over the last year, the Revenue growth was 51%. The average annual Revenue growth rates for Read Gene SA have been 24% over the past three years , 8% over the past five years , and 41% over the past ten years .

Back to Top